States Target Mylan (MYL) Exec Malik in Generic Drug-Collusion Probe - Bloomberg

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/24/2026

1. SPY
2. PATH
3. KBH
4. USO
5. AZO
6. QQQ
7. META
8. ORCL
9. RCL
10. ONON

Go back to States Target Mylan (MYL) Exec Malik in Generic Drug-Collusion Probe - Bloomberg

Expanded Generic Collusion Probe Creates 'Substantial Headline Risk' for Mylan (MYL) - Wells Fargo

October 31, 2017 12:33 PM EDT

Wells Fargo analyst David Maris weighed in on Mylan (NASDAQ: MYL) following news company President Rajiv Malik is one of two senior generic drug company executives to be individually targeted by dozens of states, according to a statement issued today from Connecticut Attorney... More

Mylan (MYL) Investigations Should Be 'Very Manageable' - Cowen

October 31, 2017 12:21 PM EDT

Cowen analyst Ken Cacciatore weighed in on Mylan (NASDAQ: MYL) amid news the ongoing antitrust investigation by the Department of Justice and various civil lawsuits from multiple States could be expanded.

Cacciatore said whatever the outcome of the many investigations, "it should be very... More

Mylan (MYL) Issues Statement in Response to Announcement of Proposed Amendments to Civil Complaint

October 31, 2017 12:04 PM EDT

Mylan N.V. (NASDAQ: MYL) provided the following statement in response to the announcement of proposed amendments to the civil complaint by various states' attorneys general in multi-district litigation pending in the U.S. District Court for the Eastern District of Pennsylvania against Mylan and 17... More